| Wockhardt gets FDA nod for Nicardipine injections | 18-NOV-09 |
|
| Drug firm Wockhardt today said it has received the final approval from the US Food and Drug Administration (FDA) for marketing Nicardipine HCI injections in 25mg/10 ml strength, used in the treatment of hypertension. |
|
|
|
|
|
|
| Venus Remedies bags patent for Potentox in SA | 12-NOV-09 |
|
| Venus Remedies has bagged patent for Potentox drug from South African patent controller. This is the company’s third product patent in South Africa this year. Companies Intellectual Property Registration Office, South Africa, has granted the company patent of two more drugs – Sulbactomax and Tobracef. |
|
|
|
| MNCs working against Indian drug firms: Sharma to WIPO | 11-NOV-09 |
|
| India today complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign against country's pharmaceutical industry, which has broken their "cartel" in the generic drugs. |
|
|
|
|
|
|
|
|
|
|
|
|
| Ranbaxy-Daiichi working on 3-yr plan for synergy | 28-OCT-09 |
|
| Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo are working on a three-year plan for exploiting synergies in operations to enhance their generic as well as branded business across the globe. |
|
|
|
| Merck acquires bioscience company Genei | 13-OCT-09 |
|
| Pharma company Merck KGaA today said it has acquired Bangalore based Genei (India) Private by its wholly-owned Indian subsidiary, Merck Specialities. |
|
|
|
| Glenmark Generics files IPO prospectus with Sebi | 30-SEP-09 |
|
| Drug maker Glenmark Pharmaceuticals today said its subsidiary Glenmark Generics has filed the draft prospectus with marker regulator Securities and Exchange Board of India (SebiI) for an initial public offer (IPO). |
|
|
|
| Dr Reddy's recalls four products from US market | 30-SEP-09 |
|
| Hyderabad-based drug firm Dr Reddy's Laboratories (DRL) today said it is recalling four of its drugs used in the treatment of ailments such as allergy, depression and high cholesterol from the US market. |
|
|
|
| Taro files lawsuit against Sun in US | 30-SEP-09 |
|
| Israeli drug firm Taro Pharmaceuticals has filed a law suit in a US district court against Mumbai-based Sun Pharmaceutical Industries alleging violation of non-disclosure agreement and misleading shareholders. |
|
|
|
| Bharat Biotech gets patent for Lysostaphin | 30-SEP-09 |
|
| Hyderabad-based vaccines and biotherapeutics manufacturer Bharat Biotech International announced on Wednesday that its anti-staphylococcal molecule Lysostaphin had secured patent rights in US, Europe, China, Australia and other nations. |
|
|
|
| Opto Circuits' US arm signs multi-year supply contract with US firm | 30-SEP-09 |
|
| Bangalore-based maker of medical diagnostic equipment, Opto Circuits (India) Ltd (OCI), today announced that its US-based subsidiary, Criticare Systems Inc (CSI), has forged a multi-year original equipment manufacturing contract with another US company to privately label its anaesthesia monitor for the US firm. |
|
|
|
| Vitamins, diabetic drugs to cost more | 29-SEP-09 |
|
| Vitamins and diabetic drugs will get costlier as the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has increased the prices of various formulation packs. |
|
|
|
Content Guide
